Anderson J R, Drehsen G, Pitman I H
J Pharm Sci. 1981 Jun;70(6):651-7. doi: 10.1002/jps.2600700619.
The effect of caffeine on the absorption of ergotamine from the rat small intestine was studied. The results of a series of experiments showed that caffeine significantly enhanced absorption of ergotamine from solutions of pH 5.0 when both substances were in solution and when an intact blood supply was either absent (in vitro everted sac experiments) or present (in situ experiments). Caffeine did not appear to influence the absorption rate of ergotamine in situ experiments when the solution pH was 3.0. Isosorbide dinitrate, a vasodilator, enhanced ergotamine absorption when both substances were administered simultaneously into intestinal loops in situ. Isosorbide dinitrate probably exerts its effect by increasing blood flow to the intestine. The results are consistent with an hypothesis that the rate-determining step in ergotamine absorption is the transport of the drug from a lipid phase (GI membrane) into an aqueous phase (blood). Caffeine is thought to exert its rate-accelerating effect by increasing the water solubility of ergotamine neutral molecules.
研究了咖啡因对麦角胺从大鼠小肠吸收的影响。一系列实验结果表明,当两种物质均处于溶液状态且在无完整血液供应(体外翻转囊实验)或有完整血液供应(原位实验)的情况下,咖啡因可显著增强麦角胺在pH 5.0溶液中的吸收。当溶液pH为3.0时,在原位实验中咖啡因似乎不影响麦角胺的吸收速率。血管扩张剂硝酸异山梨酯在两种物质同时原位注入肠袢时可增强麦角胺的吸收。硝酸异山梨酯可能通过增加肠道血流量发挥其作用。这些结果与以下假设一致,即麦角胺吸收的限速步骤是药物从脂质相(胃肠道膜)转运到水相(血液)。据认为,咖啡因通过增加麦角胺中性分子的水溶性发挥其加速吸收速率的作用。